SoftOx Solutions Investor Relations Material
Latest events
Investor Update
SoftOx Solutions
Q1 2025
27 Jun, 2025
Q4 2024
26 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SoftOx Solutions
Access all reports
SoftOx Solutions operates as a biotech company. The company focuses on the development of medical devices for diagnostics and treatment of tissue injury and other diseases. Its products include SoftOx Endo, which is used to treat tissue deterioration in the esophagus; and SoftOx Burn, which is used to prevent scarring following burn injuries.
Key slides for SoftOx Solutions
Investor Update
SoftOx Solutions
Investor Update
SoftOx Solutions
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
SOFTX
Country
🇳🇴 Norway